{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:27:01Z","timestamp":1767637621107,"version":"3.48.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29868-5","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:05:30Z","timestamp":1765037130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational identification of Moracin G and Isolonchocarpin as potent MELK inhibitors for anticancer drug discovery"],"prefix":"10.1038","volume":"16","author":[{"given":"Prathibha","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azna","family":"Zuberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"Ali Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Shahnawaz Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"29868_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"key":"29868_CR2","doi-asserted-by":"publisher","first-page":"40003","DOI":"10.1074\/jbc.M507274200","volume":"280","author":"M Beullens","year":"2005","unstructured":"Beullens, M. et al. Substrate specificity and activity regulation of protein kinase MELK. J. Biol. Chem. 280, 40003\u201340011 (2005).","journal-title":"J. Biol. Chem."},{"key":"29868_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/BJ20051844","volume":"394","author":"M Jaleel","year":"2006","unstructured":"Jaleel, M. et al. The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation. Biochem. J. 394, 545\u2013555 (2006).","journal-title":"Biochem. J."},{"key":"29868_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0378-1119(97)00181-9","volume":"195","author":"M Gil","year":"1997","unstructured":"Gil, M., Yang, Y., Lee, Y., Choi, I. & Ha, H. Cloning and expression of a cDNA encoding a novel protein serine\/threonine kinase predominantly expressed in hematopoietic cells. Gene 195, 295\u2013301 (1997).","journal-title":"Gene"},{"key":"29868_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14728222.2017.1363183","volume":"21","author":"MK Pitner","year":"2017","unstructured":"Pitner, M. K., Taliaferro, J. M., Dalby, K. N. & Bartholomeusz, C. MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. Expert Opin. Ther. Targets. 21, 849\u2013859 (2017).","journal-title":"Expert Opin. Ther. Targets"},{"key":"29868_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79, 629\u2013661 (2016).","journal-title":"J. Nat. Prod."},{"key":"29868_CR7","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1080\/07391102.2023.2228912","volume":"42","author":"A Alam","year":"2024","unstructured":"Alam, A. et al. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined Docking and molecular dynamics simulations approach. J. Biomol. Struct. Dynamics. 42, 5758\u20135769 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"29868_CR8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1021\/acs.jmedchem.7b00033","volume":"60","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. Addition and subtraction: selectivity design for type II maternal embryonic leucine zipper kinase inhibitors. J. Med. Chem. 60, 2155\u20132161 (2017).","journal-title":"J. Med. Chem."},{"key":"29868_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3324\/haematol.2017.185397","volume":"103","author":"J Muller","year":"2018","unstructured":"Muller, J. et al. Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease. Haematologica 103, 1359 (2018).","journal-title":"Haematologica"},{"key":"29868_CR10","doi-asserted-by":"publisher","first-page":"216126","DOI":"10.1016\/j.canlet.2023.216126","volume":"560","author":"BF Tang","year":"2023","unstructured":"Tang, B. F., Yan, R. C., Wang, S. W., Zeng, Z. C. & Du, S. S. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: an emerging player and promising therapeutic opportunity. Cancer Lett. 560, 216126 (2023).","journal-title":"Cancer Lett."},{"key":"29868_CR11","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","volume":"8","author":"R Vivek-Ananth","year":"2023","unstructured":"Vivek-Ananth, R., Mohanraj, K., Sahoo, A. K. & Samal, A. IMPPAT 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS Omega. 8, 8827\u20138845 (2023).","journal-title":"ACS Omega"},{"key":"29868_CR12","doi-asserted-by":"publisher","unstructured":"Mohammad, T., Mathur, Y., Hassan, M. I. & InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief. Bioinform. 22 https:\/\/doi.org\/10.1093\/bib\/bbaa279 (2021).","DOI":"10.1093\/bib\/bbaa279"},{"key":"29868_CR13","unstructured":"Visualizer, D. Discovery Studio Visualizer. 2. Accelrys software inc (2005)."},{"key":"29868_CR14","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. & Pymol An open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82\u201392 (2002).","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"29868_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"29868_CR16","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"29868_CR17","doi-asserted-by":"crossref","unstructured":"Myung, Y., de S\u00e1, A. G. & Ascher, D. B. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res. 52(W1), W469\u2013W475 (2024).","DOI":"10.1093\/nar\/gkae254"},{"key":"29868_CR18","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s11172-017-1954-x","volume":"66","author":"D Druzhilovskiy","year":"2017","unstructured":"Druzhilovskiy, D. et al. Computational platform Way2Drug: from the prediction of biological activity to drug repurposing. Russ. Chem. Bull. 66, 1832\u20131841 (2017).","journal-title":"Russ. Chem. Bull."},{"key":"29868_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/bioinformatics\/btw638","volume":"33","author":"G Janson","year":"2017","unstructured":"Janson, G., Zhang, C., Prado, M. G. & Paiardini, A. PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOL. Bioinformatics 33, 444\u2013446 (2017).","journal-title":"Bioinformatics"},{"key":"29868_CR20","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.1039\/D1RA09339H","volume":"12","author":"F Anjum","year":"2022","unstructured":"Anjum, F. et al. Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics. RSC Adv. 12, 7872\u20137882 (2022).","journal-title":"RSC Adv."},{"key":"29868_CR21","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"29868_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technol. 1, 337\u2013341 (2004).","journal-title":"Drug Discovery Today: Technol."},{"key":"29868_CR23","doi-asserted-by":"publisher","first-page":"e0311954","DOI":"10.1371\/journal.pone.0311954","volume":"20","author":"MN Sulaimani","year":"2025","unstructured":"Sulaimani, M. N. et al. Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics. PloS One. 20, e0311954 (2025).","journal-title":"PloS One"},{"key":"29868_CR24","doi-asserted-by":"publisher","first-page":"1492847","DOI":"10.3389\/fmolb.2024.1492847","volume":"11","author":"I Habib","year":"2024","unstructured":"Habib, I. et al. Identification of potential bioactive phytochemicals for the Inhibition of platelet-derived growth factor receptor \u03b2: a structure-based approach for cancer therapy. Front. Mol. Biosci. 11, 1492847 (2024).","journal-title":"Front. Mol. Biosci."},{"key":"29868_CR25","doi-asserted-by":"crossref","unstructured":"Taiyab, A. et al. Structure-guided identification of potential MTH1 inhibitors from natural compounds: toward therapeutic targeting of oxidative DNA damage in cancer. Chem. Pap. 79(3), 1477\u20131492 (2025).","DOI":"10.1007\/s11696-024-03869-6"},{"key":"29868_CR26","doi-asserted-by":"publisher","first-page":"139107","DOI":"10.1016\/j.ijbiomac.2024.139107","volume":"292","author":"A Rathi","year":"2025","unstructured":"Rathi, A. et al. FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy. Int. J. Biol. Macromol. 292, 139107 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"29868_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"GROMACS","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1. GROMACS, 19\u201325 (2015).","journal-title":"SoftwareX 1"},{"key":"29868_CR28","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Jr Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"29868_CR29","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A. 105, 9954\u20139960 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"29868_CR30","doi-asserted-by":"crossref","unstructured":"Kumari, R., Kumar, R., Consortium, O. S. D. D. & Lynn, A. g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 54, 1951\u20131962 (2014).","DOI":"10.1021\/ci500020m"},{"key":"29868_CR31","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98, 10037\u201310041 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"29868_CR32","doi-asserted-by":"publisher","first-page":"e0316343","DOI":"10.1371\/journal.pone.0316343","volume":"20","author":"M Alrouji","year":"2025","unstructured":"Alrouji, M. et al. Virtual screening and molecular dynamics simulations identify repurposed drugs as potent inhibitors of histone deacetylase 1: implication in cancer therapeutics. PloS One. 20, e0316343 (2025).","journal-title":"PloS One"},{"key":"29868_CR33","doi-asserted-by":"publisher","first-page":"e00267","DOI":"10.1042\/BSR20150194","volume":"35","author":"L Beke","year":"2015","unstructured":"Beke, L. et al. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells. Biosci. Rep. 35, e00267 (2015).","journal-title":"Biosci. Rep."},{"key":"29868_CR34","doi-asserted-by":"publisher","first-page":"19439","DOI":"10.1038\/s41598-024-69850-1","volume":"14","author":"A Shamsi","year":"2024","unstructured":"Shamsi, A. et al. Structure-based drug-development study against fibroblast growth factor receptor 2: molecular Docking and molecular dynamics simulation approaches. Sci. Rep. 14, 19439 (2024).","journal-title":"Sci. Rep."},{"key":"29868_CR35","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1021\/acs.jcim.7b00017","volume":"57","author":"Y Yan","year":"2017","unstructured":"Yan, Y., Wang, W., Sun, Z., Zhang, J. Z. & Ji, C. Protein\u2013ligand empirical interaction components for virtual screening. J. Chem. Inf. Model. 57, 1793\u20131806 (2017).","journal-title":"J. Chem. Inf. Model."},{"key":"29868_CR36","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0006-3495(03)74687-6","volume":"85","author":"I Tavernelli","year":"2003","unstructured":"Tavernelli, I., Cotesta, S. & Di Iorio, E. E. Protein dynamics, thermal stability, and free-energy landscapes: a molecular dynamics investigation. Biophys. J. 85, 2641\u20132649 (2003).","journal-title":"Biophys. J."},{"key":"29868_CR37","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3390\/molecules27103060","volume":"27","author":"C Yang","year":"2022","unstructured":"Yang, C. et al. Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase yes (YES1): implications in anticancer therapeutics. Molecules 27, 3060 (2022).","journal-title":"Molecules"},{"key":"29868_CR38","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ijbiomac.2019.06.158","volume":"136","author":"R Dahiya","year":"2019","unstructured":"Dahiya, R. et al. Investigation of inhibitory potential of Quercetin to the pyruvate dehydrogenase kinase 3: towards implications in anticancer therapy. Int. J. Biol. Macromol. 136, 1076\u20131085 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"29868_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer, N. & Gohlke, H. Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area method. Mol. Inf. 31, 114\u2013122. https:\/\/doi.org\/10.1002\/minf.201100135 (2012).","journal-title":"Mol. Inf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29868-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:41:45Z","timestamp":1767624105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29868-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29868"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29868-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}